Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer

Non-small-cell lung cancer (NSCLC) remains by far the major cause of cancer-related death in the Western world in both men and women. The majority of patients will be diagnosed with metastatic disease, and chemotherapy doublets remain the cornerstone of treatment for these patients. However, chemoth...

Full description

Saved in:
Bibliographic Details
Main Authors: Pallis, A G, Fennell, D A, Szutowicz, E, Leighl, N B, Greillier, L, Dziadziuszko, R
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2011
Subjects:
Minireview
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3137421/
https://ncbi.nlm.nih.gov/pubmed/21654681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.207
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items